Skip to main content
Erschienen in: Antimicrobial Resistance & Infection Control 1/2021

Open Access 01.12.2021 | Short report

Overuse of antibiotics in maternity and neonatal wards, a descriptive report from public hospitals in Dar es Salaam, Tanzania

verfasst von: Mwaka A. Kakolwa, Susannah L. Woodd, Alexander M. Aiken, Fatuma Manzi, Giorgia Gon, Wendy J. Graham, Abdunoor M. Kabanywanyi

Erschienen in: Antimicrobial Resistance & Infection Control | Ausgabe 1/2021

Abstract

Background

Overuse of antibiotics is a major challenge and undermines measures to control drug resistance worldwide. Postnatal women and newborns are at risk of infections and are often prescribed prophylactic antibiotics although there is no evidence to support their universal use in either group.

Methods

We performed point prevalence surveys in three hospitals in Dar es Salaam, Tanzania, in 2018 to collect descriptive data on antibiotic use and infections, in maternity and neonatal wards.

Results

Prescribing of antibiotics was high in all three hospitals ranging from 90% (43/48) to 100% (34/34) in women after cesarean section, from 1.4% (1/73) to 63% (30/48) in women after vaginal delivery, and from 89% (76/85) to 100% (77/77) in neonates. The most common reason for prescribing antibiotics was medical prophylaxis in both maternity and neonatal wards.

Conclusions

We observed substantial overuse of antibiotics in postnatal women and newborns. This calls for urgent antibiotic stewardship programs in Tanzanian hospitals to curb this inappropriate use and limit the spread of antimicrobial resistance.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AMR
Antimicrobial resistance
CS
Cesarean section
ECDC
European center for disease prevention and control
GNI
Gross national income
HAI
Healthcare associated infection
IPC
Infection prevention and control
PPS
Point prevalence survey
SSA
Sub-Saharan Africa
WHO
World health organization

Background

Overuse of antibiotics is a major challenge worldwide and undermines measures to control antimicrobial resistance (AMR). Failure to control AMR is leading to an increase in mortality, prolonged hospital stays, worsening of clinical conditions and increase in the cost for treatments [13]. AMR and specifically, resistance to antibiotic agents for treating bacterial infections, is a major problem in many African countries [46]. In Tanzania, an AMR surveillance platform has recently been implemented, but the extent of the burden of AMR currently remains unknown [7, 8]. Overuse (too much use), misuse (wrong use) or high consumption (use of large quantities) of antimicrobial drugs are closely related concepts. Collectively, these are major drivers of antimicrobial resistance [3, 9].
There are multiple reports of high levels of unnecessary prescriptions of antibiotics for both postnatal women, following either cesarean section (CS) or vaginal delivery, and neonates [1013]. In Sub-Saharan Africa (SSA), although the risk of perinatal infections is high for both mothers and neonates, limited data exists on the use of antibiotics in these groups [14].
Similarly, in Tanzania there are few formal studies of prescribing practices for antibiotics during the postpartum and neonatal period, where maternal and neonatal sepsis are estimated to be responsible for 13% and 20% mortality respectively [15, 16]. As part of a pilot study investigating impacts of an environmental hygiene intervention in Tanzanian hospitals, we aimed to describe antibiotic use in women who recently gave birth and their newborns in three hospitals in Dar es Salaam, Tanzania.

Methods

Study design and setting

We conducted point prevalence surveys (PPS) of healthcare-associated infection (HAI) and antibiotic use in maternity, gynecological and neonatal wards as part of the CLEAN study (July 2018–May 2019), a pilot evaluation of an environmental hygiene training intervention [17]. The rounds of the PPS were conducted once a month between October and December 2018. We describe the results of antibiotic use in these hospitals. The surveys were conducted in three public-sector hospitals in Dar es Salaam, Tanzania. Tanzania is an East African country with a population of more than 40 million and is graded lower-middle income by gross national income (GNI), human asset and economic vulnerability development [18, 19]. All three hospitals in this study have separate post-natal wards for vaginal delivery and CS, Hospital 1 and 2 have neonatal wards, while Hospital 3 refers sick newborns to Hospital 2. In 2017, the average number of deliveries per month per hospital was; Hospital 1-1393; Hospital 2-1125 and Hospital 3-1089.

Data collection procedure

Two doctors from each hospital’s Obstetric Department were trained in how to collect PPS data. They conducted the survey on one weekday per month for three consecutive months, with direct supervision from one investigator (AMK). Data were collected on structured questionnaires adapted from the European Centre for Disease Prevention and Control (ECDC) PPS protocol [20].This tool was originally designed to evaluate the prevalence of HAI in European healthcare facilities [20], and this also captures information on current inpatient antibiotic use. Data were collected at the level of the hospital, ward and individual patient. For individual patients, details of age, sex, date of admission, the presence of an active infection and whether the patient had been given an antimicrobial within the past 24 h of admission were collected. Identifying information including name, address and date of delivery were not collected. These data were extracted from the individual patient case-notes. The reason for prescribing antibiotics was taken from the case notes. If no explanation was provided, it was recorded as “indication unclear”. The paper-based questionnaires were stored in a locked cabinet at the study office. The database was encrypted with a password and only the study data clerk and statistician accessed the data.

Analysis

Data entry and initial cleaning was done in the HelicsWin.NeT version no 2.4, the recommended software for the analysis of the PPS in the ECDC protocol. Further cleaning and data analysis were conducted in Stata version 14.1. For each ward, the prevalence of antibiotic use was calculated as the percentage of total patients on antibiotics admitted in the ward at the time of the survey.

Results

Admission

We collected data from a total of 376 mothers and 162 newborns across three rounds of the PPS in each hospital. Hospital 1 had a total of 173 mothers and 77 newborns, hospital 2 had 258 mothers and 85 newborns, while hospital 3 had 107 mothers only.

Maternal antibiotic use

The use of antibiotics in CS wards was extremely high: 90% (43/48) of patients in Hospital 1, 96% (45/47) in Hospital 2 and 100% (34/34) in Hospital 3. In Hospital 1, all mothers with suspected infections were transferred to the gynecology ward, thus all the antibiotics prescribed in CS ward were for post-operative surgical prophylaxis. At Hospital 2, only four out of 45 mothers on antibiotic treatment were reported to have active infection; one with deep surgical site infection (SSI) (first survey) and three with superficial SSI (third survey). All other women (91%; 41/45) were receiving antibiotics for post-operative surgical prophylaxis. In Hospital 3, all admitted mothers (100%; 34/34) were on antibiotics. One SSI was reported in the first survey, but all other antibiotics were prescribed for surgical prophylaxis (see Table 1). In the post-natal vaginal delivery wards, antibiotic use varied considerably between hospitals and over time. The overall use of antibiotics was 63% (30/48) at Hospital 1, 11% (14/126) at Hospital 2, and 1.4% (1/73) at Hospital 3. At Hospital 1, use of antibiotics increased from 18% (2/11) in the first survey to 100% (22/22) in the third survey; all antibiotics were prescribed for medical prophylaxis. At Hospital 2, 11% (14/126) were prescribed antibiotics. Out of these, 7% (1/14) were for hospital-acquired episiotomy infection, 7% (1/14) were for community-acquired infection, 57% (8/14) were for medical prophylaxis and the remainder 29% (4/14) were without clear indications. At Hospital 3, only one woman (1.4%;1/73) was receiving antibiotics which was for surgical prophylaxis (see Table 2.)
Table 1
Prevalence of antibiotic use on caesarean section wards
Hospital
Survey round
Total mothers
Mothers on antibiotics n (%)
Reason for antibiotic use out of all mothers on antibiotics n (%)
Community-onset infection
Hospital-acquired infection
Medical/surgical prophylaxis
Unclear indication
Hospital 1
1
16
15 (93.8)
0
0
15 (100)
0
 
2
15
11 (83.3)
0
0
11 (100)
0
 
3
17
17 (100)
0
0
17 (100)
0
Total
 
48
43 (89.5)
0
0
43 (100)
0
Hospital 2
1
17
16 (94.1)
0
1 (6.3)
15 (93.7)
0
 
2
15
14 (93.3)
0
0
14 (100)
0
 
3
15
15 (100)
0
3 (20)
12 (80)
0
Total
 
47
45 (95.8)
0
4 (8.9)
41 (91.1)
0
Hospital 3
1
11
11 (100)
0
1 (9.1)
10 (90.9)
0
 
2
11
11 (100)
0
0
11 (100)
0
 
3
12
12 (100)
0
0
12 (100)
0
Total
 
34
34 (100)
0
1 (2.9)
33 (97.1)
0
Table 2
Prevalence of antibiotic use on post-natal wards
Hospital
Survey round
Total mothers
Mothers on antibiotics n (%)
Reason for antibiotic use out of all mothers on antibiotics n (%)
Community onset infection
Hospital acquired infection
Medical/surgical prophylaxis
Unclear indication
Hospital 1
1
11
2 (18.2)
0
0
2 (100)
0
 
2
15
6 (40.0)
0
0
6 (100)
0
 
3
22
22 (100)
0
0
22 (100)
0
Total
 
48
30 (62.5)
0
0
30 (100)
0
Hospital 2
1
36
6 (16.7)
1 (16.7)
1 (16.7)
4 (66.6)
0
 
2
45
4 (8.9)
0
0
4 (100)
0
 
3
45
4 (8.9)
0
0
0
4 (100)
Total
 
126
14 (11.1)
1 (7.1)
1 (7.1)
8 (57.2)
4 (28.6)
Hospital 3
1
20
1 (5)
0
0
1 (100)
0
 
2
26
0
0
0
0
0
 
3
27
0
0
0
0
0
Total
 
73
1 (1.4)
0
0
1 (100)
0

Neonatal antibiotic use

All newborns (77/77) in Hospital 1 were receiving antibiotics; 17% (13/77) had HAI, 1.3% (1/77) had community-acquired infection, and the rest (82%; 63/77) were being given antibiotics for medical prophylaxis. In Hospital 2, 89% (76/85) were receiving antibiotics across all three rounds of the survey, increasing from 80% (24/30) during the first round to 100% (28/28) in the third round. Out of 76 newborns on antibiotics, 4% (3/76) had community-acquired infections, 40% (30/76) had HAI and 57% (43/76) had no clear indication for antibiotic use (see Table 3).
Table 3
Prevalence of antibiotic use on neonatal wards
Hospital
Survey round
Total Neonates
Neonates on antibiotics n (%)
Reason for antibiotic use out of all neonates on Antibiotics n (%)
Community onset infection
Hospital acquired infection
Medical/surgical prophylaxis
Unclear indication
Hospital 1
1
33
33 (100)
1 (3.0)
13 (39.4)
19 (57.6)
0
 
2
26
26 (100)
0
0
26 (100)
0
 
3
18
18 (100)
0
0
18 (100)
0
Total
 
77
77 (100)
1 (1.3)
13 (16.9)
63 (81.8)
0
Hospital 2
1
30
24 (80.0)
1 (4.2)
11 (45.8)
0
12 (50)
 
2
27
24 (88.9)
1 (4.2)
9 (37.5)
0
14 (58.3)
 
3
28
28 (100)
1 (3.6)
10 (35.7)
0
17 (60.7)
Total
 
85
76 (89.4)
3 (4)
30 (39.5)
0
43 (56.5)
There was no inpatient neonatal ward in Hospital 3 at the time of survey

Discussion

We performed repeated rounds of PPS for antibiotic use in the maternity and neonatal departments of three busy public sector hospitals in urban Tanzania. We found high levels of antibiotic use in women following vaginal delivery or caesarean section. Around 95% of surveyed women who had CS were receiving antibiotics, and among these, 95% were receiving them for post-operative surgical prophylaxis lasting more than one day. The high use was observed in all three hospitals and in all surveys. Prescription of antibiotics in post-natal wards varied widely between hospitals: while Hospital 1 prescribed antibiotics in about 60% of women, Hospitals 2 and 3 only prescribed 11% and 1.4% respectively. The most common reasons for antibiotic prescription were medical or surgical prophylaxis in all hospitals. Similarly, we observed high use of antibiotics, at around 90%, in neonatal wards, with the vast majority being used for medical prophylaxis or without a clear indication. This near-universal prescription of antibiotics after CS is a common clinical practice in low income countries [2123], despite the absence of evidence or recommendations to support it. By contrast, in high income countries, the irrational use of antibiotics after CS and in maternity wards is reported to have dropped markedly over recent years [10]. This variation in practice may be explained by the onset of antibiotic stewardship programs in many hospitals in high-income countries [24]. In hospitals with limited resources, prescribing post-operative prophylactic antibiotics is likely to be influenced by concerns about high local rates of SSI, in turn attributable to weak measures for infection prevention and poor hygiene in surgical environments [25]. However, to the best of our knowledge there is no evidence that post-operative antibiotic prophylaxis helps to prevent surgical site infections. In Tanzania, infection prevention and control (IPC) data from health facilities indicates low adherence to IPC guidelines among health care workers [25, 26]. In this study, antibiotics were prescribed to one quarter of women with vaginal delivery, with substantial variation between the facilities. The highest use was reported in Hospital 1 (62.5%), most commonly for prophylaxis, whereas antibiotic use was relatively low for women following vaginal delivery in Hospital 2 (11.1%) and Hospital 3 (1.4%). We believe this wide variation between hospitals is likely to reflect differences in prescribing practices between the facilities or individual health care workers, rather than differences in infection rates, though we cannot conclusively confirm this. In other low-income settings, high use of antibiotics in women with vaginal delivery has been reported in India and Vietnam, and in a WHO study combined data from Africa, Asia and the Americas [12, 23, 26].While the study in India reported the lack of local guidelines at the time of the study as a possible factor underlying the high antibiotic prescribing rate, it was not clear whether the Vietnamese and WHO studies were in facilities with availability of guidelines for management. On the other hand, studies from Sweden and USA have reported a low use of antibiotics after vaginal delivery, reflecting the well-established nature of antibiotic stewardship programs in these countries [10, 23, 28].
In this study, we expected to see a difference in antibiotic use between the CS and vaginal delivery because CS carries higher risk of infection. Prophylactic antibiotics are recommended in CS but they should be given pre-rather than post-operatively. Irrational overuse of antibiotics is likely to ultimately lead to severe illness and death in mothers and newborns as a result of increasing levels of antibiotic resistance in low-income countries [3]. More than 90% of the admitted neonates were given antibiotics during this survey, typically as medical prophylaxis or without a clearly recorded indication. The wards were staffed by pediatricians and general practitioners, and it is possible that prescribing practice would be different among specialist neonatologists. However, specialists are rare for regional hospitals in Tanzania, so we believe our findings would be generalizable to other hospitals in Tanzania. Similarly, high use of antibiotics in neonates has been reported in one study in India where around 90% of the admitted neonates were given antibiotics [27]. Use of antibiotics in high-income countries is reported to have dropped significantly in the past years among neonates [28]. Early neonatal antibiotic exposure may be associated with morbidities such as allergy, obesity, gastrointestinal disorders and acquisition of carriage of antibiotic resistant bacteria, though the underlying evidence is weak [2931].

Study limitations

The findings in this study might have been subjected to a form of Hawthorne effect since the clinicians involved in the data collection were also working on the maternity wards and prescribing antibiotics to postnatal women. It is therefore possible that performing the survey increased their concern about infections and could have influenced their prescribing practice in later rounds of the survey. This may partly explain the increase in prescribing seen at Hospital 1 during the course of the study.

Conclusion

There was an extremely high prevalence of antibiotic prescribing for prophylaxis in maternal and neonatal units in hospitals in Dar es Salaam, Tanzania. Better infection control policies, local and national guidelines, and antimicrobial stewardship programs need to be implemented to avoid unnecessary prescription of the antibiotics and promotion of antibiotic resistance.

Acknowledgements

We thank all the doctors and nurses who took part during the survey. We also thank the administration and medical officers in charge of all hospitals who gave us permission to collect data in the respective hospitals.

Declarations

The CLEAN study was approved by the ethics committee of Tanzanian National Institute of Medical Research (NIMR), Ifakara Health Institute (IHI) Institutional Review Board, and the ethics committee of the London School of Hygiene and Tropical Medicine (LSHTM).
Not applicable.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
3.
Zurück zum Zitat Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen J-A, Klugman K, et al. Access to effective antimicrobials: a worldwide challenge. The Lancet. 2016;387(10014):168–75.CrossRef Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen J-A, Klugman K, et al. Access to effective antimicrobials: a worldwide challenge. The Lancet. 2016;387(10014):168–75.CrossRef
5.
Zurück zum Zitat Bebell LM, Ngonzi J, Bazira J, Fajardo Y, Boatin AA, Siedner MJ, et al. Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital. PLoS ONE. 2017;12(4):e0175456.CrossRef Bebell LM, Ngonzi J, Bazira J, Fajardo Y, Boatin AA, Siedner MJ, et al. Antimicrobial-resistant infections among postpartum women at a Ugandan referral hospital. PLoS ONE. 2017;12(4):e0175456.CrossRef
6.
Zurück zum Zitat Tadesse BT, Ashley EA, Ongarello S, Havumaki J, Wijegoonewardena M, Gonzalez IJ, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):616.CrossRef Tadesse BT, Ashley EA, Ongarello S, Havumaki J, Wijegoonewardena M, Gonzalez IJ, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):616.CrossRef
8.
Zurück zum Zitat Sangeda RZ, Kibona J, Munishi C, Arabi F, Manyanga VP, Mwambete KD, et al. Assessment of implementation of antimicrobial resistance surveillance and antimicrobial stewardship programs in tanzanian health facilities a year after launch of the national action plan. Front Public Health. 2020;8:856.CrossRef Sangeda RZ, Kibona J, Munishi C, Arabi F, Manyanga VP, Mwambete KD, et al. Assessment of implementation of antimicrobial resistance surveillance and antimicrobial stewardship programs in tanzanian health facilities a year after launch of the national action plan. Front Public Health. 2020;8:856.CrossRef
10.
Zurück zum Zitat Andrikopoulou M, Huang Y, Duffy CR, Stern-Ascher CN, Wright JD, Goffman D, et al. Antibiotic use without indication during delivery hospitalizations in the United States. Obstet Gynecol. 2019;134(4):718–25.CrossRef Andrikopoulou M, Huang Y, Duffy CR, Stern-Ascher CN, Wright JD, Goffman D, et al. Antibiotic use without indication during delivery hospitalizations in the United States. Obstet Gynecol. 2019;134(4):718–25.CrossRef
11.
Zurück zum Zitat Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H, et al. High rates of prescribing antimicrobials for prophylaxis in children and neonates: results from the antibiotic resistance and prescribing in European children point prevalence survey. J Pediatr Infect Dis Soc. 2019;8(2):143–51.CrossRef Hufnagel M, Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H, et al. High rates of prescribing antimicrobials for prophylaxis in children and neonates: results from the antibiotic resistance and prescribing in European children point prevalence survey. J Pediatr Infect Dis Soc. 2019;8(2):143–51.CrossRef
12.
Zurück zum Zitat Liabsuetrakul T, Lumbiganon P, Mori R, Gulmezoglu M, Souza JP, Maternal WHOGSo, et al. A secondary analysis of the WHO Global Survey on Maternal and Perinatal Health for antibiotics used in vaginal deliveries. Int J Gynaecol Obstet. 2014;124(3):240–3.CrossRef Liabsuetrakul T, Lumbiganon P, Mori R, Gulmezoglu M, Souza JP, Maternal WHOGSo, et al. A secondary analysis of the WHO Global Survey on Maternal and Perinatal Health for antibiotics used in vaginal deliveries. Int J Gynaecol Obstet. 2014;124(3):240–3.CrossRef
13.
Zurück zum Zitat MartinezdeTejada B. Antibiotic use and misuse during pregnancy and delivery: benefits and risks. Int J Environ Res Public Health. 2014;11(8):7993–8009.CrossRef MartinezdeTejada B. Antibiotic use and misuse during pregnancy and delivery: benefits and risks. Int J Environ Res Public Health. 2014;11(8):7993–8009.CrossRef
14.
Zurück zum Zitat Essack SY, Desta AT, Abotsi RE, Agoba EE. Antimicrobial resistance in the WHO African region: current status and roadmap for action. J Public Health (Oxf). 2017;39(1):8–13. Essack SY, Desta AT, Abotsi RE, Agoba EE. Antimicrobial resistance in the WHO African region: current status and roadmap for action. J Public Health (Oxf). 2017;39(1):8–13.
15.
Zurück zum Zitat Pembe A, Paul C, Dmello B, Roosemalen J. Maternal mortality at Muhimbili in Dar es salaam, Tanzania in the year 2011. BMC Pregnancy Childbirth. 2014;14:320.CrossRef Pembe A, Paul C, Dmello B, Roosemalen J. Maternal mortality at Muhimbili in Dar es salaam, Tanzania in the year 2011. BMC Pregnancy Childbirth. 2014;14:320.CrossRef
17.
Zurück zum Zitat Gon G, Kabanywanyi AM, Blinkhoff P, Cousens S, Dancer SJ, Graham WJ, et al. The Clean pilot study: evaluation of an environmental hygiene intervention bundle in three Tanzanian hospitals. Antimicrob Resist Infect Control. 2021;10(1):8.CrossRef Gon G, Kabanywanyi AM, Blinkhoff P, Cousens S, Dancer SJ, Graham WJ, et al. The Clean pilot study: evaluation of an environmental hygiene intervention bundle in three Tanzanian hospitals. Antimicrob Resist Infect Control. 2021;10(1):8.CrossRef
21.
Zurück zum Zitat De Nardo P, Gentilotti E, Nguhuni B, Vairo F, Chaula Z, Nicastri E, et al. Post-caesarean section surgical site infections at a Tanzanian tertiary hospital: a prospective observational study. J Hosp Infect. 2016;93(4):355–9.CrossRef De Nardo P, Gentilotti E, Nguhuni B, Vairo F, Chaula Z, Nicastri E, et al. Post-caesarean section surgical site infections at a Tanzanian tertiary hospital: a prospective observational study. J Hosp Infect. 2016;93(4):355–9.CrossRef
22.
Zurück zum Zitat Morisaki N, Ganchimeg T, Ota E, Vogel JP, Souza JP, Mori R, et al. Maternal and institutional characteristics associated with the administration of prophylactic antibiotics for caesarean section: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl 1):66–75.CrossRef Morisaki N, Ganchimeg T, Ota E, Vogel JP, Souza JP, Mori R, et al. Maternal and institutional characteristics associated with the administration of prophylactic antibiotics for caesarean section: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG. 2014;121(Suppl 1):66–75.CrossRef
23.
Zurück zum Zitat Sharma M, Sanneving L, Mahadik K, Santacatterina M, Dhaneria S, Stalsby LC. Antibiotic prescribing in women during and after delivery in a non-teaching, tertiary care hospital in Ujjain, India: a prospective cross-sectional study. J Pharm Policy Pract. 2013;6:9.CrossRef Sharma M, Sanneving L, Mahadik K, Santacatterina M, Dhaneria S, Stalsby LC. Antibiotic prescribing in women during and after delivery in a non-teaching, tertiary care hospital in Ujjain, India: a prospective cross-sectional study. J Pharm Policy Pract. 2013;6:9.CrossRef
24.
Zurück zum Zitat Schuts EC, Hulscher MEJL, Mouton JW, Verduin CM, Stuart JWTC, Overdiek HWPM, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847–56.CrossRef Schuts EC, Hulscher MEJL, Mouton JW, Verduin CM, Stuart JWTC, Overdiek HWPM, et al. Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis. Lancet Infect Dis. 2016;16(7):847–56.CrossRef
25.
Zurück zum Zitat Bonet M, Ota E, Chibueze CE, Oladapo OT. Antibiotic prophylaxis for episiotomy repair following vaginal birth. Cochrane Database Syst Rev. 2017;11:CD012136.PubMed Bonet M, Ota E, Chibueze CE, Oladapo OT. Antibiotic prophylaxis for episiotomy repair following vaginal birth. Cochrane Database Syst Rev. 2017;11:CD012136.PubMed
26.
Zurück zum Zitat Ngoc TN, Sloan NL, Thach TS, Liem LKB, Winikoff B. Incidence of Postpartum infection after vaginal Delivery in Vietnam. J Health Popul Nutr. 2015;23(2):121–30. Ngoc TN, Sloan NL, Thach TS, Liem LKB, Winikoff B. Incidence of Postpartum infection after vaginal Delivery in Vietnam. J Health Popul Nutr. 2015;23(2):121–30.
27.
Zurück zum Zitat Hauge C, Stalsby Lundborg C, Mandaliya J, Marrone G, Sharma M. Up to 89% of neonates received antibiotics in cross-sectional Indian study including those with no infections and unclear diagnoses. Acta Paediatr. 2017;106(10):1674–83.CrossRef Hauge C, Stalsby Lundborg C, Mandaliya J, Marrone G, Sharma M. Up to 89% of neonates received antibiotics in cross-sectional Indian study including those with no infections and unclear diagnoses. Acta Paediatr. 2017;106(10):1674–83.CrossRef
28.
Zurück zum Zitat Schulman J, Profit J, Lee HC, Duenas G, Bennett MV, Parucha J, et al. Variations in neonatal antibiotic use. Pediatrics. 2018;142(3):e20180115.CrossRef Schulman J, Profit J, Lee HC, Duenas G, Bennett MV, Parucha J, et al. Variations in neonatal antibiotic use. Pediatrics. 2018;142(3):e20180115.CrossRef
29.
Zurück zum Zitat Partap U, Allcock SH, Parker E, Gurdasani D, Young EH, Sandhu MS. Association between early life antibiotic use and childhood overweight and obesity: a narrative review. Glob Health Epidemiol Genom. 2018;3:e18.CrossRef Partap U, Allcock SH, Parker E, Gurdasani D, Young EH, Sandhu MS. Association between early life antibiotic use and childhood overweight and obesity: a narrative review. Glob Health Epidemiol Genom. 2018;3:e18.CrossRef
30.
Zurück zum Zitat Salvatore S, Baldassarre ME, Di Mauro A, Laforgia N, Tafuri S, Bianchi FP, et al. Neonatal antibiotics and prematurity are associated with an increased risk of functional gastrointestinal disorders in the first year of life. J Pediatr. 2019;212:44–51.CrossRef Salvatore S, Baldassarre ME, Di Mauro A, Laforgia N, Tafuri S, Bianchi FP, et al. Neonatal antibiotics and prematurity are associated with an increased risk of functional gastrointestinal disorders in the first year of life. J Pediatr. 2019;212:44–51.CrossRef
31.
Zurück zum Zitat Yamamoto-Hanada K, Yang L, Narita M, Saito H, Ohya Y. Influence of antibiotic use in early childhood on asthma and allergic diseases at age 5. Ann Allergy Asthma Immunol. 2017;119(1):54–8.CrossRef Yamamoto-Hanada K, Yang L, Narita M, Saito H, Ohya Y. Influence of antibiotic use in early childhood on asthma and allergic diseases at age 5. Ann Allergy Asthma Immunol. 2017;119(1):54–8.CrossRef
Metadaten
Titel
Overuse of antibiotics in maternity and neonatal wards, a descriptive report from public hospitals in Dar es Salaam, Tanzania
verfasst von
Mwaka A. Kakolwa
Susannah L. Woodd
Alexander M. Aiken
Fatuma Manzi
Giorgia Gon
Wendy J. Graham
Abdunoor M. Kabanywanyi
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
Antimicrobial Resistance & Infection Control / Ausgabe 1/2021
Elektronische ISSN: 2047-2994
DOI
https://doi.org/10.1186/s13756-021-01014-6

Weitere Artikel der Ausgabe 1/2021

Antimicrobial Resistance & Infection Control 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.